Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryoablation of PENG vs Fascia Iliaca Catheter in Hip Fracture
NCT06278987Phase 4Withdrawn
- Sponsor
- University of Minnesota
- Start
- Oct 2024
- Primary completion
- Oct 2027
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by University of Minnesota. Primary endpoints: Maximum pain score at 30 days, Opioid use at day 7 and 5 more. Planned start Oct 2024; status: withdrawn.
Beyond the preview
Go deeper on NCT06278987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06278987.